Loading…

The Treatment of Ingrown Nail: Chemical Matricectomy With Phenol Versus Aesthetic Reconstruction. A Single Blinded Randomized Clinical Trial

In onychocryptosis surgery, incisional and non-incisional matricectomy is indicated according to the stage. The chemical matricectomy with 88% phenol solution is the gold standard and a wedge resection is indicated for more advanced stages. The aesthetic reconstruction has the advantages of the inci...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2020-03, Vol.9 (3), p.845
Main Authors: Muriel-Sánchez, Juan Manuel, Becerro-de-Bengoa-Vallejo, Ricardo, Montaño-Jiménez, Pedro, Coheña-Jiménez, Manuel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c406t-3462510ba167f0776c425dd3b21a41873031c366763cb4d3a9fe0ff262da70623
cites cdi_FETCH-LOGICAL-c406t-3462510ba167f0776c425dd3b21a41873031c366763cb4d3a9fe0ff262da70623
container_end_page
container_issue 3
container_start_page 845
container_title Journal of clinical medicine
container_volume 9
creator Muriel-Sánchez, Juan Manuel
Becerro-de-Bengoa-Vallejo, Ricardo
Montaño-Jiménez, Pedro
Coheña-Jiménez, Manuel
description In onychocryptosis surgery, incisional and non-incisional matricectomy is indicated according to the stage. The chemical matricectomy with 88% phenol solution is the gold standard and a wedge resection is indicated for more advanced stages. The aesthetic reconstruction has the advantages of the incisional procedure without eponychium incisions and an effectiveness similar to the chemical matricectomy with phenol. To compare the recurrence and the healing time between the chemical matricectomy with phenol and the aesthetic reconstruction. A comparative, prospective, parallel, randomized, and one-blinded clinical trial was registered with the European Clinical Trials Database (EudraCT) with identification number 2019-001294-80. Thrity-four patients (56 feet) with 112 onychocryptosis were randomized in two groups. Thirty-six were treated with chemical matricectomy with phenol and 76 with aesthetic reconstruction. Each patient was blind to the surgical procedure assigned by the investigator. The primary outcome measurements were healing time and recurrence. The secondary outcome measurements were post-surgical bleeding, pain, inflammation, and infection rate. The aesthetic reconstruction procedure presents a shorter healing time (8.2 ± 1.4 days vs. 21.3 ± 3.1 days; < 0.001) with a similar recurrence rate ( = 0.98). Post-operatory bleeding, pain, inflammation, and the infection rate did not show significant differences ( > 0.05). The aesthetic reconstruction presents a shorter healing time, favoring the patients' recuperation, with a recurrence similar to the chemical matricectomy with 88% phenol solution.
doi_str_mv 10.3390/jcm9030845
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7141528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2641160019</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-3462510ba167f0776c425dd3b21a41873031c366763cb4d3a9fe0ff262da70623</originalsourceid><addsrcrecordid>eNpdkV1rFTEQhoMottTe-AMk4I0Ip-Zrk10vhOPBj0L9oB71MuRkZ8_mkE1qkm2pv8EfbbS1VudmhpmHl3l5EXpIyRHnHXm2s1NHOGlFcwftM6LUgvCW370176HDnHekVtsKRtV9tMcZE6KTch_9WI-A1wlMmSAUHAd8HLYpXgT83jj_HK9GmJw1Hr8zJTkLtsTpEn91ZcQfRwjR4y-Q8pzxEnIZoTiLT8HGkEuabXExHOEl_uTC1gN-6V3oocenJvRxct_ruKqr3_Lr5Ix_gO4Nxmc4vO4H6PPrV-vV28XJhzfHq-XJwgoiy4ILyRpKNoZKNVSX0grW9D3fMGoEbRUnnFoupZLcbkTPTTcAGQYmWW8UkYwfoBdXumfzZoLeVufJeH2W3GTSpY7G6X8vwY16G8-1ooI2rK0CT64FUvw2V-d6ctmC9yZAnLNmvJVMSdk0FX38H7qLcwrVnmZSUCoJoV2lnl5RNsWcEww3z1Cif-Ws_-Zc4Ue3379B_6TKfwIza6Ox</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641160019</pqid></control><display><type>article</type><title>The Treatment of Ingrown Nail: Chemical Matricectomy With Phenol Versus Aesthetic Reconstruction. A Single Blinded Randomized Clinical Trial</title><source>Publicly Available Content Database</source><source>PubMed Central(OpenAccess)</source><creator>Muriel-Sánchez, Juan Manuel ; Becerro-de-Bengoa-Vallejo, Ricardo ; Montaño-Jiménez, Pedro ; Coheña-Jiménez, Manuel</creator><creatorcontrib>Muriel-Sánchez, Juan Manuel ; Becerro-de-Bengoa-Vallejo, Ricardo ; Montaño-Jiménez, Pedro ; Coheña-Jiménez, Manuel</creatorcontrib><description>In onychocryptosis surgery, incisional and non-incisional matricectomy is indicated according to the stage. The chemical matricectomy with 88% phenol solution is the gold standard and a wedge resection is indicated for more advanced stages. The aesthetic reconstruction has the advantages of the incisional procedure without eponychium incisions and an effectiveness similar to the chemical matricectomy with phenol. To compare the recurrence and the healing time between the chemical matricectomy with phenol and the aesthetic reconstruction. A comparative, prospective, parallel, randomized, and one-blinded clinical trial was registered with the European Clinical Trials Database (EudraCT) with identification number 2019-001294-80. Thrity-four patients (56 feet) with 112 onychocryptosis were randomized in two groups. Thirty-six were treated with chemical matricectomy with phenol and 76 with aesthetic reconstruction. Each patient was blind to the surgical procedure assigned by the investigator. The primary outcome measurements were healing time and recurrence. The secondary outcome measurements were post-surgical bleeding, pain, inflammation, and infection rate. The aesthetic reconstruction procedure presents a shorter healing time (8.2 ± 1.4 days vs. 21.3 ± 3.1 days; &lt; 0.001) with a similar recurrence rate ( = 0.98). Post-operatory bleeding, pain, inflammation, and the infection rate did not show significant differences ( &gt; 0.05). The aesthetic reconstruction presents a shorter healing time, favoring the patients' recuperation, with a recurrence similar to the chemical matricectomy with 88% phenol solution.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm9030845</identifier><identifier>PMID: 32244966</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Clinical trials ; Infections ; Inflammation ; Pain ; Phenols ; Physiology ; Surgery</subject><ispartof>Journal of clinical medicine, 2020-03, Vol.9 (3), p.845</ispartof><rights>2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-3462510ba167f0776c425dd3b21a41873031c366763cb4d3a9fe0ff262da70623</citedby><cites>FETCH-LOGICAL-c406t-3462510ba167f0776c425dd3b21a41873031c366763cb4d3a9fe0ff262da70623</cites><orcidid>0000-0001-5714-6594 ; 0000-0003-1568-7602</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2641160019/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2641160019?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32244966$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muriel-Sánchez, Juan Manuel</creatorcontrib><creatorcontrib>Becerro-de-Bengoa-Vallejo, Ricardo</creatorcontrib><creatorcontrib>Montaño-Jiménez, Pedro</creatorcontrib><creatorcontrib>Coheña-Jiménez, Manuel</creatorcontrib><title>The Treatment of Ingrown Nail: Chemical Matricectomy With Phenol Versus Aesthetic Reconstruction. A Single Blinded Randomized Clinical Trial</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>In onychocryptosis surgery, incisional and non-incisional matricectomy is indicated according to the stage. The chemical matricectomy with 88% phenol solution is the gold standard and a wedge resection is indicated for more advanced stages. The aesthetic reconstruction has the advantages of the incisional procedure without eponychium incisions and an effectiveness similar to the chemical matricectomy with phenol. To compare the recurrence and the healing time between the chemical matricectomy with phenol and the aesthetic reconstruction. A comparative, prospective, parallel, randomized, and one-blinded clinical trial was registered with the European Clinical Trials Database (EudraCT) with identification number 2019-001294-80. Thrity-four patients (56 feet) with 112 onychocryptosis were randomized in two groups. Thirty-six were treated with chemical matricectomy with phenol and 76 with aesthetic reconstruction. Each patient was blind to the surgical procedure assigned by the investigator. The primary outcome measurements were healing time and recurrence. The secondary outcome measurements were post-surgical bleeding, pain, inflammation, and infection rate. The aesthetic reconstruction procedure presents a shorter healing time (8.2 ± 1.4 days vs. 21.3 ± 3.1 days; &lt; 0.001) with a similar recurrence rate ( = 0.98). Post-operatory bleeding, pain, inflammation, and the infection rate did not show significant differences ( &gt; 0.05). The aesthetic reconstruction presents a shorter healing time, favoring the patients' recuperation, with a recurrence similar to the chemical matricectomy with 88% phenol solution.</description><subject>Clinical trials</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Pain</subject><subject>Phenols</subject><subject>Physiology</subject><subject>Surgery</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkV1rFTEQhoMottTe-AMk4I0Ip-Zrk10vhOPBj0L9oB71MuRkZ8_mkE1qkm2pv8EfbbS1VudmhpmHl3l5EXpIyRHnHXm2s1NHOGlFcwftM6LUgvCW370176HDnHekVtsKRtV9tMcZE6KTch_9WI-A1wlMmSAUHAd8HLYpXgT83jj_HK9GmJw1Hr8zJTkLtsTpEn91ZcQfRwjR4y-Q8pzxEnIZoTiLT8HGkEuabXExHOEl_uTC1gN-6V3oocenJvRxct_ruKqr3_Lr5Ix_gO4Nxmc4vO4H6PPrV-vV28XJhzfHq-XJwgoiy4ILyRpKNoZKNVSX0grW9D3fMGoEbRUnnFoupZLcbkTPTTcAGQYmWW8UkYwfoBdXumfzZoLeVufJeH2W3GTSpY7G6X8vwY16G8-1ooI2rK0CT64FUvw2V-d6ctmC9yZAnLNmvJVMSdk0FX38H7qLcwrVnmZSUCoJoV2lnl5RNsWcEww3z1Cif-Ws_-Zc4Ue3379B_6TKfwIza6Ox</recordid><startdate>20200320</startdate><enddate>20200320</enddate><creator>Muriel-Sánchez, Juan Manuel</creator><creator>Becerro-de-Bengoa-Vallejo, Ricardo</creator><creator>Montaño-Jiménez, Pedro</creator><creator>Coheña-Jiménez, Manuel</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5714-6594</orcidid><orcidid>https://orcid.org/0000-0003-1568-7602</orcidid></search><sort><creationdate>20200320</creationdate><title>The Treatment of Ingrown Nail: Chemical Matricectomy With Phenol Versus Aesthetic Reconstruction. A Single Blinded Randomized Clinical Trial</title><author>Muriel-Sánchez, Juan Manuel ; Becerro-de-Bengoa-Vallejo, Ricardo ; Montaño-Jiménez, Pedro ; Coheña-Jiménez, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-3462510ba167f0776c425dd3b21a41873031c366763cb4d3a9fe0ff262da70623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Clinical trials</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Pain</topic><topic>Phenols</topic><topic>Physiology</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muriel-Sánchez, Juan Manuel</creatorcontrib><creatorcontrib>Becerro-de-Bengoa-Vallejo, Ricardo</creatorcontrib><creatorcontrib>Montaño-Jiménez, Pedro</creatorcontrib><creatorcontrib>Coheña-Jiménez, Manuel</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muriel-Sánchez, Juan Manuel</au><au>Becerro-de-Bengoa-Vallejo, Ricardo</au><au>Montaño-Jiménez, Pedro</au><au>Coheña-Jiménez, Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Treatment of Ingrown Nail: Chemical Matricectomy With Phenol Versus Aesthetic Reconstruction. A Single Blinded Randomized Clinical Trial</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2020-03-20</date><risdate>2020</risdate><volume>9</volume><issue>3</issue><spage>845</spage><pages>845-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>In onychocryptosis surgery, incisional and non-incisional matricectomy is indicated according to the stage. The chemical matricectomy with 88% phenol solution is the gold standard and a wedge resection is indicated for more advanced stages. The aesthetic reconstruction has the advantages of the incisional procedure without eponychium incisions and an effectiveness similar to the chemical matricectomy with phenol. To compare the recurrence and the healing time between the chemical matricectomy with phenol and the aesthetic reconstruction. A comparative, prospective, parallel, randomized, and one-blinded clinical trial was registered with the European Clinical Trials Database (EudraCT) with identification number 2019-001294-80. Thrity-four patients (56 feet) with 112 onychocryptosis were randomized in two groups. Thirty-six were treated with chemical matricectomy with phenol and 76 with aesthetic reconstruction. Each patient was blind to the surgical procedure assigned by the investigator. The primary outcome measurements were healing time and recurrence. The secondary outcome measurements were post-surgical bleeding, pain, inflammation, and infection rate. The aesthetic reconstruction procedure presents a shorter healing time (8.2 ± 1.4 days vs. 21.3 ± 3.1 days; &lt; 0.001) with a similar recurrence rate ( = 0.98). Post-operatory bleeding, pain, inflammation, and the infection rate did not show significant differences ( &gt; 0.05). The aesthetic reconstruction presents a shorter healing time, favoring the patients' recuperation, with a recurrence similar to the chemical matricectomy with 88% phenol solution.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32244966</pmid><doi>10.3390/jcm9030845</doi><orcidid>https://orcid.org/0000-0001-5714-6594</orcidid><orcidid>https://orcid.org/0000-0003-1568-7602</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2020-03, Vol.9 (3), p.845
issn 2077-0383
2077-0383
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7141528
source Publicly Available Content Database; PubMed Central(OpenAccess)
subjects Clinical trials
Infections
Inflammation
Pain
Phenols
Physiology
Surgery
title The Treatment of Ingrown Nail: Chemical Matricectomy With Phenol Versus Aesthetic Reconstruction. A Single Blinded Randomized Clinical Trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T01%3A03%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Treatment%20of%20Ingrown%20Nail:%20Chemical%20Matricectomy%20With%20Phenol%20Versus%20Aesthetic%20Reconstruction.%20A%20Single%20Blinded%20Randomized%20Clinical%20Trial&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Muriel-S%C3%A1nchez,%20Juan%20Manuel&rft.date=2020-03-20&rft.volume=9&rft.issue=3&rft.spage=845&rft.pages=845-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm9030845&rft_dat=%3Cproquest_pubme%3E2641160019%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c406t-3462510ba167f0776c425dd3b21a41873031c366763cb4d3a9fe0ff262da70623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2641160019&rft_id=info:pmid/32244966&rfr_iscdi=true